These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19394134)

  • 1. Editorial comment on: complete continence after botulinum neurotoxin type a injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks.
    Kilinc M; Guven S
    Eur Urol; 2010 May; 57(5):895-6. PubMed ID: 19394134
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: complete continence after botulinum neurotoxin type a injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks.
    Giannantoni A
    Eur Urol; 2010 May; 57(5):896. PubMed ID: 19394135
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks.
    Khan S; Panicker J; Roosen A; Gonzales G; Elneil S; Dasgupta P; Fowler CJ; Kessler TM
    Eur Urol; 2010 May; 57(5):891-6. PubMed ID: 19394133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
    Schmid DM; Roy S; Sulser T; Scheiner D
    BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.
    Kessler TM; Khan S; Panicker JN; Elneil S; Brandner S; Fowler CJ; Roosen A
    Eur Urol; 2010 May; 57(5):879-83. PubMed ID: 19765885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.
    Khan S; Kessler TM; Apostolidis A; Kalsi V; Panicker J; Roosen A; Gonzales G; Haslam C; Elneil S; Fowler CJ; Dasgupta P
    J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder.
    Rovner E; Kennelly M; Schulte-Baukloh H; Zhou J; Haag-Molkenteller C; Dasgupta P
    Neurourol Urodyn; 2011 Apr; 30(4):556-62. PubMed ID: 21351127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.
    Herschorn S; Gajewski J; Ethans K; Corcos J; Carlson K; Bailly G; Bard R; Valiquette L; Baverstock R; Carr L; Radomski S
    J Urol; 2011 Jun; 185(6):2229-35. PubMed ID: 21497851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis.
    Khan S; Game X; Kalsi V; Gonzales G; Panicker J; Elneil S; Apostolidis A; Hamid R; Dasgupta P; Kessler TM; Fowler CJ
    J Urol; 2011 Apr; 185(4):1344-9. PubMed ID: 21334639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical electromotive botulinum toxin type A administration--part II: Clinical application.
    Kajbafzadeh AM; Ahmadi H; Montaser-Kouhsari L; Sharifi-Rad L; Nejat F; Bazargan-Hejazi S
    Urology; 2011 Feb; 77(2):439-45. PubMed ID: 20800886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children.
    Blackburn SC; Jones C; Bedoya S; Steinbrecher HA; Malone PS; Griffin SJ
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):750-3. PubMed ID: 23036518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of Clostridium botulinum type A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity.
    Lee JC; Yokoyama T; Hwang HJ; Arimitsu H; Yamamoto Y; Kawasaki M; Takigawa T; Takeshi K; Nishikawa A; Kumon H; Oguma K
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):201-11. PubMed ID: 17692094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A.
    Charrua A; Avelino A; Cruz F
    Handb Exp Pharmacol; 2011; (202):345-74. PubMed ID: 21290235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.
    Kuo HC; Liao CH; Chung SD
    Eur Urol; 2010 Dec; 58(6):919-26. PubMed ID: 20864251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged urinary retention after intravesical botulinum injection for treatment of idiopathic detrusor overactivity.
    King AB; Rapp DE
    Can J Urol; 2011 Apr; 18(2):5657-9. PubMed ID: 21504656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Haferkamp A
    Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial.
    Abdel-Meguid TA
    J Urol; 2010 Dec; 184(6):2423-8. PubMed ID: 20952003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Input from a specialized nurse consultation in the management of detrusor overactivity treated with intradetrusor injections of botulinum toxin in urology department. Pilot study].
    Le Gal S; Safsaf A; Galliot I; Catovic B; Grise P
    Prog Urol; 2010 Sep; 20(8):584-9. PubMed ID: 20832036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Injection of botulinum toxin (BTX-A) in children with bladder dysfunction due to detrusor overactivity].
    Romero RM; Rivas S; Parente A; Fanjul M; Angulo JM
    Actas Urol Esp; 2011 Feb; 35(2):89-92. PubMed ID: 21256633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin as a treatment for refractory overactive bladder.
    Harris S; Rizzolo D
    JAAPA; 2016 Feb; 29(2):1-4. PubMed ID: 26818640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.